Intérêt de l'obtention immédiate des résultats d'analyse biologique en néphrologie clinique

Abstract

We have recently evaluated in the Nephrology-Dialysis department of the Central Hospital of Sens (Yonne, France) the automated analyzer Mercury 16 (Nova Biomedical) which can perform routine biological testing in non-centrifuged blood, urine or dialysate and deliver the results on-line. The clinical interest of creatinine, urea, sodium, potassium, chloride, total CO2, hematocrit and glucose measurements is recalled. This evaluation was an opportunity to rethink the daily work of a nephrology practitioner in a hospital structure belonging to a care network. Out patient examinations often allow to detect and prevent developing renal diseases or other diseases altering the renal function, situations in which it can be important to have access to the patient's biological values without any delay. Replacement renal treatments increasingly tend to be performed outside the heavy and cost-consuming hospital structures in satellite units. Both these units and central hospital structures would benefit of the reliability and rapidity of validated biological results that could be to sent to practitioners in the central structure, allowing quick diagnosis and choice of the best adapted treatment. It appears therefore that the possibilities offered by this automated analyzer would yield benefits for the end stage renal disease patient as for the nephrology practitioner and the cost coverage service.